Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risvodetinib succinate by Inhibikase Therapeutics for Constipation: Likelihood of Approval
Risvodetinib succinate is under clinical development by Inhibikase Therapeutics and currently in Phase I for Constipation. According to GlobalData, Phase...
Data Insights
Risvodetinib succinate by Inhibikase Therapeutics for Dysphagia: Likelihood of Approval
Risvodetinib succinate is under clinical development by Inhibikase Therapeutics and currently in Phase I for Dysphagia. According to GlobalData, Phase...